Nephrogenic adenoma: Immunohistochemical evaluation for its etiology and differentiation from prostatic adenocarcinoma

Archives of Pathology and Laboratory Medicine

Volumn 130, Issue 6, 2006, Pages 805-810

  Xiao, Guang Qian ^a   Burstein, David E ^a   Miller, Lorraine K ^a   Unger, Pamela D ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; EPITHELIAL MEMBRANE ANTIGEN; P504S ANTIGEN; PROSTATE SPECIFIC ANTIGEN; PROTEIN P63; UNCLASSIFIED DRUG; 2 METHYLACYL COENZYME A RACEMASE; ALPHA-METHYLACYL-COA RACEMASE; CA 15-3 ANTIGEN; ISOMERASE; TUMOR MARKER;

ARTICLE; BASAL CELL; BENIGN TUMOR; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY ADENOMA; KIDNEY TUBULE; MALE; PROSTATE ADENOCARCINOMA; ADENOCARCINOMA; ADENOMA; CHEMISTRY; DIFFERENTIAL DIAGNOSIS; METHODOLOGY; PATHOLOGY; PROSTATE TUMOR; URINARY TRACT CANCER; UROTHELIUM;

ADENOCARCINOMA; ADENOMA; CA-15-3 ANTIGEN; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROSTATIC NEOPLASMS; RACEMASES AND EPIMERASES; TUMOR MARKERS, BIOLOGICAL; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 33745019689     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Piper NY, Thompson IM. Large rtephrogertic adenoma following transurethral resection of the prostate. J Urol. 1999;161:605.
2. Ford TF, Watson GM, Cameron KM. Adenomatous metaplasia (nephrogenic adenoma) of urothelium: an analysis of 70 cases. Br J Urol. 1985;57:427-433.
3. Kilciler M, Tan O, Ozgok Y, et al. Nephrogenic adenoma of the bladder after intravesical bacillus Calmette-Guerin treatment. Urol Int. 2000;64:229-232.
4. Paik SS, Lee JD. Nephrogenic adenoma arising in a urethral diverticulum. Br J Urol. 1997;80:150.
5. Tse V, Khadra M, Eisinger D, et al. Nephrogenic adenoma of the bladder in renal transplant and non-renal transplant patients: a review of 22 cases. Urology. 1997;50:690-696.
6. Banyai-Falger S, Maier U, Susani M, et al. High incidence of nephrogenic adenoma of the bladder after renal transplantation. Transplantation. 1998;65:511-514.
7. Porcaro AB, D'Amico A, Ficarra V, et al. Nephrogenic adenoma of the urinary bladder: our experience and review of the literature. Urol Int. 2001;66:152-155.
8. Oliva E, Young RH. Nephrogenic adenoma of the urinary tract: a review of the microscopic appearance of 80 cases with emphasis on unusual features. Mod Pathol. 1995;8:722-730.
9. Friedman NB, Kühlenbeck H. Adenomatoid tumors of the bladder reproducing renal structures (nephrogenic adenoma). J Urol. 1950;64:657-670.
10. Mazal PR, Schaufler R, Altenhuber-Muller R, et al. Derivation of nephrogenic adenomas from renal tubular cells in kidney-transplant recipients. N Engl J Med 2002;347:653-659.
11. Allan CH, Epstein JI. Nephrogenic adenoma of the prostatic urethra: a mimicker of prostate adenocarcinoma. Am J Surg Pathol. 2001;25:802-808.
12. Peeker R, Aldenborg F, Fall M. Nephrogenic adenoma: a study with special reference to clinical presentation. Br J Urol. 1997;80:539-542.
13. Azumi M, Tokumitsu M, Saga Y, et al. Nephrogenic adenoma of the bladder in children. Nippon Hinyokika Gakkai Zasshi. 2002;93:495-498.
14. Heidenreich A, Zirbes TK, Wolter S, Engelmann UH. Nephrogenic adenoma: a rare bladder tumor in children. Eur Urol. 1999;36:348-353.
15. Gaylis FD, Keer HN, Bauer KD, et al. DNA profile of nephrogenic adenoma assessed by flow cytometry. Urology. 1993;41:160-161.
16. Dörrenhaus A, Müller JI, Golka K, et al. Cultures of exfoliated epithelial cells from different locations of the human urinary tract and the renal tubular system. Arch Toxicol. 2000;74:618-626.
17. Di Como CJ, Urist MJ, Babayan I, et al. p63 expression profiles in human normal and tumor tissues. Clin Cancer Res. 2002;8:494-501.
18. Jiang Z, Fanger GR, Woda BA, et al. Expression of alpha-methylacyl-CoA racemase (P504S) in various malignant neoplasms and normal tissues: a study of 761 cases. Hum Pathol. 2003;34:792-796.
19. Langner C, Ratschek M, Rehak P, et al. CD10 is a diagnostic and prognostic marker in renal malignancies. Histopathology. 2004;45:460-467.
20. Asamoto M, Fukushima S, Oosumi H, et al. Immunohistochemical distribution of epithelial membrane antigen in bladder carcinomas as detected with a monoclonal antibody. Urol Res. 1989;17:273-277.
21. Gupta A, Wang HL, Policarpio-Nicolas ML, et al. Expression of alphamethylacyl-coenzyme A racemase in nephrogenic adenoma. Am J Surg Pathol. 2004;28:1224-1229.
22. Gilcrease MZ, Delgado R, Vuitch F, Albores-Saavedra J. Clear cell adenocarcinoma and nephrogenic adenoma of the urethra and urinary bladder: a histopathologic and immunohistochemical comparison. Hum Pathol. 1998;29:1451-1456.
23. Malpica A, Ro JY, Troncoso P, et al. Nephrogenic adenoma of the prostatic urethra involving the prostate gland: a clinicopathologic and immunohistochemical study of eight cases. Hum Pathol. 1994;25:390-395.
24. Genega EM, Hutchinson B, Reuter VE, Gaudin PB. Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma. Mod Pathol. 2000;13:1186-1191.